Science Magazine says some researchers are coming to see menopause as a stress test for the brain.
Science Magazine says women are more likely than men to develop dementia, and not only because they tend to live longer. Menopause may be one reason: Some researchers are coming to see the midlife drop in sex hormones as a stress test for the brain.
36.6K
1 Source, first seen ago
Women develop dementia more often than men, and longer average lifespans do not appear to explain the entire difference. Researchers are increasingly studying menopause as a neurological transition, not only a reproductive one. A Science report describes the midlife shift in sex hormones as a possible “stress test” for the brain.
A new study in Nature Medicine offers a molecular clue. The researchers found a pattern of 16 blood proteins that changed across menopause and overlapped with biological processes related to inflammation, synaptic health, metabolism and Alzheimer’s disease.
The findings do not show that menopause causes dementia. They identify an association that could help scientists study why some brains remain resilient while others become more vulnerable later in life.
The discovery stage included 80 healthy women ages 43 to 58 who were carefully classified as premenopausal, perimenopausal or postmenopausal. None were taking menopausal hormone therapy. The researchers also included 36 age-matched men for comparison.
—
Not ranked yet
—
Not ranked yet
The composite protein score rose step by step across the menopause stages. The overall pattern was more strongly associated with changes in estradiol and follicle-stimulating hormone than with chronological age. Proteins involved in inflammation tended to increase as estradiol fell, while a separate group linked to Alzheimer’s biology increased with follicle-stimulating hormone.
The team then tested the pattern in 2,814 age-matched women from the UK Biobank using a different protein-measurement platform. That analysis reproduced the broad menopause-related shifts and also linked them with signs of accelerated aging across several organ and cell systems, including the brain.
To explore whether the same molecular pattern mattered later in life, the researchers examined four independent cohorts totaling 11,925 older women. Higher menopause-related protein scores were consistently associated with less favorable cognitive outcomes and dementia risk.
According to UCSF’s account of the study, women with the highest levels of the molecules had worse memory and a 15% higher risk of developing Alzheimer’s disease. Women who reported night sweats also tended to have greater increases in inflammatory proteins.
Those numbers describe groups, not an individual diagnosis. The study did not test whether changing any of the proteins would prevent cognitive decline, and the proposed blood signature is not a clinical screening test.
The work is observational, so it cannot establish that menopause or the protein shifts directly cause dementia. The initial cohort was also small, blood-protein levels can fluctuate, and much of the same signature appeared in the male comparison group. Most people who go through menopause do not develop Alzheimer’s disease.
Larger studies that follow participants through the full menopause transition are now being organized. Researchers plan to combine repeated blood samples with brain imaging, cognitive testing and symptom tracking. Those data could show whether the molecular pattern predicts later change within the same person and whether it reflects a menopause-specific process or a broader feature of midlife aging.
